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Christian Fankhauser3, Karim Saba3, Ashkan Mortezavi3, Cédric Poyet3, Thomas Hermanns3,
Yi Zhu2, Holger Moch1, Ruedi Aebersold2,4 & Peter J. Wild1,5
Microscopy image data of human cancers provide detailed phenotypes of spatially and morphologically
intact tissues at single-cell resolution, thus complementing large-scale molecular analyses, e.g., next
generation sequencing or proteomic proﬁling. Here we describe a high-resolution tissue microarray (TMA)
image dataset from a cohort of 71 prostate tissue samples, which was hybridized with bright-ﬁeld dual
colour chromogenic and silver in situ hybridization probes for the tumour suppressor gene PTEN. These
tissue samples were digitized and supplemented with expert annotations, clinical information, statistical
models of PTEN genetic status, and computer source codes. For validation, we constructed an additional
TMA dataset for 424 prostate tissues, hybridized with FISH probes for PTEN, and performed survival
analysis on a subset of 339 radical prostatectomy specimens with overall, disease-speciﬁc and recurrence-
free survival (maximum 167 months). For application, we further produced 6,036 image patches derived
from two whole slides. Our curated collection of prostate cancer data sets provides reuse potential for both
biomedical and computational studies.
Design Type(s) disease state design • cell type comparison design
Measurement Type(s) Gene Deletion • cell image data
Technology Type(s)
chromosome organization assay by ﬂuorescence in situ hybridization
• Chromogenic In Situ Hybridization • microscopy assay
Factor Type(s) diagnosis
Sample Characteristic(s) Homo sapiens • prostate gland • lymph node
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Background & Summary
Technical advances of large-scale molecular studies, including next generation genomic analyses and
proteomic proﬁling, of human tissue samples have enabled discovery of genetic and other molecular
aberrations in different regions of a tumour, deﬁned as intra-tumour heterogeneity (ITH), having critical
implications in precise diagnosis and treatment of cancers1–5. Yet, such studies often evaluate samples
prepared from homogenised tissues and exclude corresponding histo-morphology, thereby failing to
investigate molecular changes and to identify minor sub-clones at single-cell level.
We have recently developed an integrative method (ISHProﬁler), combining an image-based
computational workﬂow with a dual-colour chromogenic and silver in situ hybridization assay (DISH)
that accurately detects copy number variation (CNV) with preserved histo-morphology at single-cell
resolution, expressively visualizes multi-level heterogeneity (cellular, inter-, and intra-tumour hetero-
geneity), and objectively quantiﬁes heterogeneous allelic gains and losses of various genes in diverse
human tumours hybridized with molecular probes6. Our ISHProﬁler supports broad applications in
biomedical and computational research and alleviates the limitations of the gold standard method,
ﬂuorescence in situ hybridization (FISH)7. These include error-prone manual counting under a
ﬂuorescence microscope, severe inter-observer variability, and qualitative assessment of genetic status8–10.
To benchmark the ISHProﬁler, we have analysed a large number of stained tissue microarray (TMA)
images with associated clinical data6. Here, we provide a more detailed description of these data and
guarantee their open access for future data re-mining studies. Our collection of benign and malignant
prostate formalin-ﬁxed, parafﬁn-embedded (FFPE) tissue samples consist of PTEN DISH images of a
TMA with corresponding signal colour maps of the PTEN gene and the corresponding centromeric probe
(CEP) of chromosome 10 (n= 71; Fig. 1), matching hematoxylin and eosin (H&E) images from the serial
sections (n= 71), patches of two whole slide PTEN DISH images (n= 3,726 and n= 2,310), patient-level
annotations (n= 71), clinical information (n= 424), survival data (n= 339), computational models
(n= 71), and computer source codes (Table 1). The 424 prostate FFPE tissue samples comprises 339
radical prostatectomy (RPE) specimens, 28 castration resistant prostate cancers (CRPCs), 17 lymph node
metastases (LNM), 11 distant metastases (DM), and 29 benign prostatic hyperplasias (BPHs). In addition,
the survival data exhibit a median follow-up of 95 months and a maximum of 167 months for the 339
RPE samples with additional clinico-pathological, immunological and molecular data (Table 2).
In comparison to comprehensive data collections such as TCGA4, CAMELYON16 (camelyon16.
grand-challenge.org), TUPAC16 (www.tupac.tue-image.nl), and HER2 scoring contest (warwick.ac.uk/
fac/sci/dcs/research/combi/research/bic/her2contest), our data resource is small but well curated. It
combines images, genetic information, and the clinical data, into a uniﬁed computational model that
quantiﬁes PTEN genetic status as distribution. The data reveals multi-level tumour heterogeneity and
alleviates the problem that genetic status is traditionally a binary classiﬁcation. A potential reuse of this
collection of data will be the investigation of whether a quantitative, model-based description of a
heterogeneous genetic status is superior compared to a binary decision, when associating the results with
clinical outcomes.
Although our related work6 quantiﬁes the genetic alteration and tumour heterogeneity by classifying
molecular signals of interest without consideration of tumour cell recognition11,12, the digitized DISH
images retain intact tissue morphology, thus potentially enabling studies that address the detection of
tumorous tissues and the re-analysis of genetic aberrations at single-cell resolution.
With patient-level annotation of PTEN genetic status of the 71 prostate cancer TMA samples acquired
by two different scanning protocols, computational scientists can reuse the dataset for testing whether
molecular signals such as genes of interests and the corresponding CEP can be recognized in an
unsupervised fashion or independently of scanning procedures, thus completely avoiding the labour-
intensive, error-prone, and subjective manual annotation of these molecular signals.
Selection of tumour tissue regions for high-throughput molecular proﬁling, such as genomic and
proteomic studies, is currently accomplished by staining whole slide tissues with H&E, immnuhis-
tochemistry (IHC) or in situ hybridization (ISH), followed by manual evaluation of small selected regions
of interest by trained pathologists6. Our quantitative signal colour map produced by ISHProﬁler, which
preserves tissue topology and combines genetic analysis with clinico-pathological assessment, offers an
alternative approach for hotspot tissue region selection from heterogeneous tumour tissues with a high
degree of accuracy, objectivity and reproducibility.
Methods
The following methods are either modiﬁed, shortened or expanded versions of the methods and
Supplementary Information in our related work6.
Prostate cancer patients
A total of 424 FFPE tissue samples were retrieved from the archives of the Department of Pathology and
Molecular Pathology, University Hospital Zurich, Switzerland13–17. One tissue core (diameter 0.6 mm and
thickness of 4 μm) of a representative tumour area per patient was taken from a ‘donor’ block and was
arranged in a new ‘recipient’ block using a customized instrument. The TMA included a series of
consecutive (non-selected) RPE specimens with localized prostate cancer, CRPCs, LNM, DM and BPHs.
H&E-stained slides of all specimens were evaluated by two experienced pathologists to identify
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representative areas for TMA construction (H.M., P.J.W.). Specimens were annotated with clinical
information such as patient demographics, histological ﬁndings, treatment, and outcome data including
overall and disease-speciﬁc survival as well as biochemical (PSA) recurrence. Tumour stage and Gleason
score of the cohort were assigned according to the International Union Against Cancer (UICC) and
WHO/ISUP 2016 criteria. Gleason scores were assigned by two independent investigators (P.J.W., H.M.)
and a consensus was achieved in case of discrepant results by both investigators. Effectively, 424 samples
were used in the FISH analysis and a subset of 71 samples was used for DISH manual assessment and
computational analysis (Data Citations 1–3). The DISH subset comprises 38 primary acinar
adenocarcinomas from RPE, 10 CRPCs, six PC LNM, one DM, and 16 BPHs. The study was approved
by the Cantonal Ethics Committee of Zurich (StV-No. 2008-0025) and the associated methods were
carried out in accordance with the approved guidelines.
PTEN FISH analysis
For PTEN deletion analysis, a dual-colour FISH was performed using commercially available DNA
probes for the region 10q23.3 (Spectrum Orange, PTEN locus-speciﬁc probe; Abbott Molecular) and
10p11.1-q11.1 (Spectrum Green, CEP of chromosome 10; LSI PTEN/CEP10; Abbott Molecular), as
described previously10. In detail, four micron thick sections were deparafﬁnized in xylene before
immersion in 100% ethanol. Sections were then placed in 10 mM citrate buffer (pH 6.0) at 96 °C for 15
min, followed by treatment with pepsin (Medite GmbH) at 37 °C for 40 min. Sections were dehydrated
in a graded series of ethanol. Probes and target DNA were co-denatured at 75 °C for 10 min.
Post-hybridization washings were performed with 2x SSC solution at room temperature and 73 °C for
2 min. Slides were then air-dried in dark. Nuclei were counterstained with 40,6-diamidino-2-phenylindole
(DAPI) in an antifade solution. Each tissue core was evaluated for each FISH probe by manually counting
signals in 20–60 intact non-overlapping interphase nuclei, using a ﬂuorescence microscope (Leica
DM6000 B). Manual scoring (Data Citation 3) was performed in tumour areas with loss of PTEN signals.
The average of two experienced pathologists’ manual, independent assessment led to the ﬁnal score. Two
homogeneous genetic alteration
deletion no deletion
LNMLNMCRPC CRPC RPERPE
heterogeneous genetic alteration 
H&E
DISH
Signal
Colour
Map
Figure 1. Sample tissue cores of matching H&E images, DISH images, and signal colour maps. Six
examples of H&E images (top row), DISH images (middle row), and signal colour maps (bottom row) with
patient-level expert annotations, such as tissue types and PTEN genetic status. Signal colour maps can be
generated by our ISHProﬁler software. For the signal colour maps, black signals indicate the PTEN gene, red
signals indicate the CEP10, and green signal indicate the mixed classes PTEN+CEP10. CRPC, castration
resistant prostate cancer; LNM, lymph node metastases; RPE, radical prostatectomy.
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scoring methods were used: the percentage of aberrant nuclei and the ratio of PTEN to CEP10 signals. As
a threshold for PTEN deletion, the percentage of aberrant nuclei was used in accordance to a previous
publication18: hemizygous PTEN deletion was deﬁned as the presence of fewer PTEN signals than CEP10
signals in at least 60% of counted nuclei. Homozygous PTEN deletion was deﬁned if at least one third
(33%) of aberrant nuclei revealed zero PTEN signal in a tissue core, with the presence of one or two PTEN
signals in adjacent normal cells. Accordingly, PTEN deletion was deﬁned if the average ratio of PTEN to
CEP10 signals was less than or equal to 60%.
Subjects Protocol 1 Protocol 2 Protocol 3 Protocol 4 Data
Prostate cancer TMA
(n= 71)
DISH staining and
digitization by Zeiss
Manual assessment Computational analysis
(Matlab codes)
Comparison with FISH
and patient-level
annotation
Data Citation 1
Prostate cancer TMA
(n= 71)
DISH and H&E staining
and digitization by
Hamamatsu
Manual assessment Computational analysis
(Matlab codes)
Comparison with FISH
and patient-level
annotation
Data Citation 2
Prostate cancer
(n= 424)
FISH staining, collection
of clinical and survival
data
Manual assessment Kaplan-Meier estimator
(R codes)
Univariate and
multivariate Cox
regression
Data Citation 3
Prostate cancer and two
whole slide images
(n= 3,726; n= 2,310)
DISH staining and
digitization
NA Computational analysis Post visual inspection Data Citation 4
Prostate cancer TMA
(n= 71) and two whole
slide images (n= 3,726;
n= 2,310)
DISH and H&E staining
and digitization by
Hamamatsu
NA NA Output.ndpi ﬁle format Data Citation 5
Table 1. Summary of DISH images, PTEN genetic status, clinical information and survival data of
patient cohorts with prostate cancer.
Variable Name Description (range or categorization)
TMA References the ‘Loc’ variable in demo1.xlsx (ISHProﬁler
®
) (e.g., A_1_1)
rfs Recurrence-free survival (0–163 months)
st_rfs Status for recurrence-free survival (0: censored, 1: recurrence, 3: never reached
nadir)
os Overall survival (0–167months)
st_os_gen Status for overall survival (0: censored, 1: any death)
st_os_spec Status for disease-speciﬁc survival (0: censored, 1: death from prostate cancer)
tiss Tissue type (1: RPE, 2: CRPC, 3: LNM, 4: DM, 8: BPH)
age_d64 Age at RPE (dichotomization by 64) (0o64 years, 1≥ 64 years)
BMI_d25 Body mass index (dichotomization by 25) (0≤ 25 kgm2, 1>25 kgm2)
GLE_t Gleason score (1: Gleason score 5–6, 2: 7, 3: 8–10)
pT_t Tumour stage (1: pT2, 2: pT3, 3: pT4)
pN Nodal status (0: no tumour, 1: positive surgical margin)
R1 Surgical margin status (0: R0, 1: R1)
PSA_d10 PSA at diagnosis (dichotomization by 10) (0o10 ngml1, 1≥ 10 ngml1)
PTEN_cyt PTEN IHC (cytoplasmic intensity) (0: negative, 1: weak, 2: moderate, 3:
strong)
SPOP SPOP mutation FD (0: wild-type, 1: mutated)
ERG ERG break-apart FISH (0: FISH− , 1: FISH+)
PTEN_FISH_ratio PTEN FISH ratio (0.28–1.00)
PTEN_FISH_ratio_d60 PTEN FISH ratio (dichotomization by 0.6) (0: no deletion (>0.6), 1: PTEN
deletion (≤0.6))
PTEN_FISH_percent_ab_nucl PTEN FISH % aberrant nuclei (0–1.00)
PTEN_FISH_percent_d60 PTEN FISH % aberrant nuclei (dichotomization by 0.6) (0: no deletion
(o60%), 1: PTEN deletion (≥60%))
PTEN_total_signals Total PTEN FISH signals (10–123)
nuclei_number Number of nuclei analysed (9–40)
CEP10_total_signals Total CEP10 FISH signals (17–127)
Table 2. Summary of clinical and survival data.
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PTEN DISH analysis
A BenchMark ULTRA automated stainer was used for the optimization and performance evaluation of
the DISH assay for CEP10 and PTEN DNA targets. In this assay, a black signal represented the PTEN
probe, a red signal corresponded to the CEP10, which were visualized with ultraView SISH DNP and Red
ISH DIG detection kit respectively, after hybridization with the PTEN DNP probe and CEP10 probe
cocktail. All tissue sections were counterstained with hematoxylin II and bluing reagent (Ventana).
Air-dried glass slides were coverslipped using the Tissue-Tek Film automated coverslipper
(Sakura Finetek Japan). The threshold of 60% for the ratio was used.
Image-based computational workﬂow (ISHProﬁler)
Tissue cores or slides were digitized and pre-processed (white balancing, deconvolution, and contrast
modiﬁcation) using the scanner’s default auto-correction settings. Images were then resized by bicubic
interpolation to 4,096 × 4,096 pixels for efﬁcient tiling (4,096= 212) and served as input data for the
computational workﬂow. Pseudocode of the workﬂow was provided in the Supplementary Information of
our related study6.
The basic workﬂow consists of three major algorithmic steps: First, each tissue was digitized,
pre-processed, and resized. Second, DISH signals were detected by the circular Hough transform19. Third,
a support vector machine (SVM) model20 was trained and validated (5-fold cross validation and grid
search that iterates over all pairs of C and gamma) on an independent image set from a single tissue spot
with the expert annotation, consisting of 1,000 image patches of size 13 × 13 pixels with PTEN, CEP10,
PTEN+CEP10, white background noise and blue cell stains in the centre of the patch. The feature vector
was constructed by concatenating (13 × 13= 169) RGB values. The ﬁnal model was used to classify the
signals into ﬁve classes: PTEN, CEP10, mixed classes PTEN+CEP10, background noise and cell stains.
For reduction of misclassiﬁed signals, only gene and corresponding CEP signals were used for
subsequent calculation. Signals classiﬁed as white or blue were discarded. The maximum of the global
ratio was set to three to circumvent false positive gene signals due to unspeciﬁc staining (any roundish
black signals) for cases with gene deletion. About 30% of signals were classiﬁed as PTEN or CEP10.
Analogous to the ratio scoring method, the global ratio was deﬁned as the division of all PTEN by all
CEP10 signals in a single tissue core.
For the circular Hough transform, the signal radii were deﬁned empirically from 1 to 7 pixels
according to domain knowledge and the edge gradient threshold was set to Matlab default (Otsu's
method). The detection sensitivity was set to Matlab default (0.85) for tissues scanned by the Zeiss
scanner and was set to 0.95 for tissues digitized by the Hamamatsu scanner, because the Zeiss scanner has
a higher image resolution and a more advanced sensor.
Based on the class and position of detected molecular signals, a signal colour map can be generated to
visualize heterogeneous PTEN deletion. Moreover, advanced algorithms can be used for quantifying
genetic alteration and investigating tumour heterogeneity6.
The computational workﬂow was implemented in Matlab (R2014b) and tested on a MacPro (2014).
Matlab built-in functions for the circular Hough transform (imﬁndcircles) and ROC analysis (perfcurve)
were used. The software package LIBSVM21 (version 3.18) was used to train, validate and test SVM
models on the data.
Code availability
The Matlab demo codes with initial parameter settings can be downloaded from https://github.com/
zhoqi/SD_ISHProﬁler. A basic workﬂow that classiﬁes PTEN and CEP10 DISH signals has been
integrated into the open source software TMARKER22 as a JAVA plug-in and is available at: http://www.
nexus.ethz.ch/equipment_tools/software/tmarker/Plugins.html. In addition, R codes for survival analysis
with Kaplan-Meier estimator and univariate and multivariate Cox regression are also openly available at:
https://github.com/zhoqi/SD_survival.
Data Records
Image data
An image dataset (JPEG ﬁle format) of the PTEN DISH assay of 71 prostate cancer tissue samples, which
were digitized by a Carl Zeiss Axio Scan.Z1 scanner, with a scanning resolution of 40x (0.11 μm per
pixel). The native image resolution is 7,000 × 7,000 pixels for a single tissue core. Each tissue core is
named as *_PTEN_Zeiss_7000.jpg, where * stands for the sample ID. A single tissue core as used in our
related work6 has an image resolution of 4,096 × 4,096 pixels, which is named as *_PTEN_Zeiss_4096.jpg
(Data Citation 1). Detailed technical speciﬁcation of the scanner of the Zeiss scanner can be found at:
http://applications.zeiss.com/C125792900358A3F/0/EC2B774E2EB1662AC1257ACB00506F68/$FILE/
EN_41_011_023_Axio_Scan_Z1.pdf.
An image dataset (JPEG ﬁle format) of PTEN DISH assay of 71 prostate cancer tissue samples, which
were digitized by a Hamamatsu C9600 NanoZoomer 2.0-HT Digital slide scanner, with a resolution of
40x (0.23 μm per pixel). The original image resolution is 3,100 × 3,100 pixels for a single tissue core,
which is named as *_PTEN_Hamamatsu.jpg. In addition, 71 corresponding H&E images, named
as *_HE_Hamamatsu.jpg, from serial sections were digitized by the same Hamamatsu scanner
www.nature.com/sdata/
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(Data Citation 2). Detailed technical speciﬁcation of the Hamamatsu scanner can be found at: http://
www.hamamatsu.com/resources/pdf/sys/SBIS0043E_NanoZoomers.pdf.
A whole tissue slide (108,000 × 138,000 pixels) of a transurethrally resected CRPC sample, which was
hybridized with PTEN DISH and digitized with a Hamamatsu C9600 NanoZoomer 2.0-HT Digital slide
scanner. The whole tissue side image (JPEG ﬁle format) was tiled into 3,726 single image patches of size
2,000 × 2,000 pixels, which were organized according to the accompanying README ﬁle and the
overview image ‘B12-7405_8_boxes.jpg’ in PTEN.zip (Data Citation 4).
A second whole tissue slide (84,000 × 110,000 pixels) of an intra-ductal carcinoma of the prostate
(IDC-P), which was hybridized with PTEN DISH and digitized with a Hamamatsu C9600 NanoZoomer
2.0-HT Digital slide scanner. The whole tissue side image (JPEG ﬁle format) was tiled into 2,310 single
image patches of size 2,000 × 2,000 pixels, which were organized according to the accompanying
README ﬁle and the overview image ‘B05-41379_10_boxes.jpg’ in PTEN_IDCP.zip (Data Citation 4).
Each tissue image was provided in its native.ndpi format, which can be handled by the OpenSlide
(www.openslide.org) software. The.ndpi TMA DISH image contains all 71 images (PTEN_Hamamatsu.
ndpi). The same applies to the.ndpi TMA H&E image (HE_Hamamatsu.ndpi). The two whole slide
images (B12-7405_8.ndpi and B05-41379_10.ndpi) are provided in original resolution and not tiled into
2,000 × 2,000 pixels (Data Citation 5). Individual TMA cores in PTEN_Hamamatsu.ndpi and
HE_Hamamatsu.ndpi are ordered as A_1_1, A_2_1, …, A_8_1, B_1_1, B_2_1, … B_8_1 from left to
right, and A_1_1, A_1_2, …, A_1_13 from top to bottom.
Clinical and survival data
Clinical and survival data of 424 prostate cancer patients (SPSS ﬁle format and tab-delimited format) with
manual annotation of PTEN FISH for 339 RPE cases (Data Citation 3). The column names and their
descriptions are listed in Table 2.
Technical Validation
Validated by independent images
The set of 71 DISH tissue cores was digitized by the bright-ﬁeld and ﬂuorescence slide scanner
(Carl Zeiss) according to manufacturer’s instructions. In addition, we also performed a second
digitization by using a Hamamatsu scanner. With application of the same parameter settings of circular
Hough transform and SVM model, our image-based computational workﬂow produced similar
classiﬁcation results for both image datasets (r= 0.83, Po0.0001), independent of scanning resolution
and quality.
Validation on two whole slide images
The whole slide image with 108,000 × 138,000 pixels was tiled into 3,726 image patches of size
2,000 × 2,000 pixels. We then used the same parameter settings as the TMAs for the calculation of circular
Hough transform and the SVM model to detect and classify molecular signals. A landscape of PTEN
deletion was generated by merging all signal colour maps of each image patches. The heterogeneous
PTEN status matched closely to a serial section that was immunohistochemically stained with anti-PTEN
antibody (Dako; clone 6H2.1)6. We performed the same validation on a second whole slide image with
84,000 × 110,000 pixels and obtained a similar result.
Statistical validation of survival data
Nonparametric Kaplan-Meier estimators were used to analyse the overall, disease-speciﬁc and
recurrence-free survival of the 339 RPE cases, of which 298 patients have median follow-up of 95
months with a variety of clinico-pathological, immunohistochemical and molecular features. We
provided the original SPSS ﬁle (Data Citation 3) and R source codes (Code availability) for plotting a
Kaplan-Meier curve for the overall survival (Fig. 2a,b) and for performing analysis of univariate and
multivariable Cox regression (Fig. 2c), in which multivariate stepwise reverse selection was set to P= 0.1
as the limit. The ﬁgures shown in this section are a modiﬁed version of Supplementary Figs 2 and 3 in our
related work6, in which additional Kaplan-Meier curves for disease-speciﬁc and recurrence-free survival
and forest plots for univariate Cox regression were reported.
Usage Notes
Brief instructions
The ﬁrst dataset (Data Citation 1) comprises high quality images that were scanned by a Carl Zeiss Axio
Scan.Z1 scanner. The leading part of the ﬁlename (e.g., A_1_1 from A_1_1 _PTEN_Zeiss_4096) matches
the corresponding identiﬁer in the ﬁrst column of the annotation ﬁle demo1.xlsx (Loc: TMA core
location; label: No deletion versus deletion; type: tissue type including BHP, RPE, CRPC, LNM, and DM;
DISH_Manual: manual assessment of PTEN to CEP10 ratio).
To use ISHProﬁler software, perform the following tasks.
1. Download the Matlab code from https://github.com/zhoqi/SD_ISHProﬁler.
2. Install LIBSVM, version 3.18 or above, in the same directory as demo1.m.
www.nature.com/sdata/
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3. Download the 71 images, named as *_PTEN_Zeiss_4096.jpg from (Data Citation 1), and place them
in the directory ‘/images’.
4. Run demo1.m, demo2.m and demo3.m.
The ﬁle demo1.m outputs the global ratios for all 71 tissue cores. It also plots a sample tissue core
image, superimposed with detected and classiﬁed PTEN gene and CEP signals. The PTEN signals are in
black, CEP10 signals in red, and the mixed classes of PTEN+CEP10 signals in green. The ﬁle demo2.m
plots pairwise distances of 71 tissue cores in the two-dimensional principal component analysis subspace,
color-coded by PTEN DISH expert annotation. The ﬁle demo3.m plots six sample signal colour maps and
outputs a computational model that speciﬁes the position and colour of the detected molecular signals for
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Model with stepwise reverse selection
Variable         Characteristics Overall survival (hazard ratio [95% CI]) p-value
Global model
Figure 2. Survival analysis of 339 RPE patients. Kaplan-Meier curves with simultaneous 95% conﬁdence
bands of patient overall survival over time after diagnosis. Vertical lines illustrate patients who were censored at
the time of their last clinical follow-up visit. Differences between survival estimates were evaluated by the
log-rank test. N values represent the number of patients in each group under risk. For P-value, Po0.05 is
marked in bold. (a) Kaplan-Meier curves for patients who were dichotomized into two groups by the
percentage aberrant nuclei. (b) Kaplan-Meier curves for patients who were dichotomized into two groups by
the ratio. (c) Overall survival hazard ratios by Cox regression. The dashed vertical line was drawn at the no
effect point (hazard ratio of 1.0). Horizontal lines represent a 95% conﬁdence interval (CI). The mid-point of
the box represents the mean effect estimate and the area of the box represents the weight for each subgroup.
Limit for the stepwise reverse selection procedure was P= 0.1.
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each tissue core. With modiﬁcations of demo2.m, users can apply the code to the other datasets
(Data Citations 2 and 4), without changing the pre-trained SVM model model.mat. For computational
scientists, they can explore these rich datasets by providing their own user annotations or perform
unsupervised learning of genetic alteration and tumour heterogeneity.
Survival analysis of the 339 RPE prostate cancer patients recorded in the SPSS ﬁle (Data Citation 3)
can be performed by running the R code pten_surv.R (Code availability), which generates plots as in
(Fig. 2) and in our related work6. Make sure that the external packages survival, OIsurv and foreign are
pre-installed.
We are going to prepare a series of multi-omics (genomics, transcriptomics and proteomics) datasets,
which are based on the same patient cohort of this manuscript. Therefore, the clinical and survival data of
424 prostate cancer patients serves as a master ﬁle for future reference (Data Citation 3).
Access controls
Access permission to data and computer codes will be granted for research purpose only. Any interested
researcher who will use the clinical survival data (Data Citation 3) is required to agree to the terms and
conditions given by the authors prior to data access.
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